Labcorp Holdings EPS - Earnings per Share 2012-2025 | LH
Labcorp Holdings annual and quarterly earnings per share history from 2012 to 2025. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Labcorp Holdings EPS for the quarter ending September 30, 2025 was $3.12, a 56% increase year-over-year.
- Labcorp Holdings EPS for the twelve months ending September 30, 2025 was $10.20, a 93.55% increase year-over-year.
- Labcorp Holdings 2024 annual EPS was $8.84, a 85.32% increase from 2023.
- Labcorp Holdings 2023 annual EPS was $4.77, a 65.86% decline from 2022.
- Labcorp Holdings 2022 annual EPS was $13.97, a 42.72% decline from 2021.
| Labcorp Holdings Annual EPS | |
|---|---|
| 2024 | $8.84 |
| 2023 | $4.77 |
| 2022 | $13.97 |
| 2021 | $24.39 |
| 2020 | $15.88 |
| 2019 | $8.35 |
| 2018 | $8.61 |
| 2017 | $11.81 |
| 2016 | $6.82 |
| 2015 | $4.35 |
| 2014 | $5.91 |
| 2013 | $6.25 |
| 2012 | $5.99 |
| 2011 | $5.11 |
| Labcorp Holdings Quarterly EPS | |
|---|---|
| 2025-09-30 | $3.12 |
| 2025-06-30 | $2.84 |
| 2025-03-31 | $2.52 |
| 2024-12-31 | $1.72 |
| 2024-09-30 | $2.00 |
| 2024-06-30 | $2.43 |
| 2024-03-31 | $2.69 |
| 2023-12-31 | $-1.85 |
| 2023-09-30 | $2.11 |
| 2023-06-30 | $2.12 |
| 2023-03-31 | $2.39 |
| 2022-12-31 | $0.97 |
| 2022-09-30 | $3.90 |
| 2022-06-30 | $3.87 |
| 2022-03-31 | $5.23 |
| 2021-12-31 | $5.76 |
| 2021-09-30 | $6.05 |
| 2021-06-30 | $4.76 |
| 2021-03-31 | $7.82 |
| 2020-12-31 | $9.61 |
| 2020-09-30 | $7.17 |
| 2020-06-30 | $2.37 |
| 2020-03-31 | $-3.27 |
| 2019-12-31 | $2.31 |
| 2019-09-30 | $2.25 |
| 2019-06-30 | $1.93 |
| 2019-03-31 | $1.86 |
| 2018-12-31 | $1.57 |
| 2018-09-30 | $3.10 |
| 2018-06-30 | $2.27 |
| 2018-03-31 | $1.67 |
| 2017-12-31 | $6.63 |
| 2017-09-30 | $1.65 |
| 2017-06-30 | $1.78 |
| 2017-03-31 | $1.75 |
| 2016-12-31 | $1.57 |
| 2016-09-30 | $1.71 |
| 2016-06-30 | $1.96 |
| 2016-03-31 | $1.58 |
| 2015-12-31 | $1.15 |
| 2015-09-30 | $1.50 |
| 2015-06-30 | $1.66 |
| 2015-03-31 | $0.04 |
| 2014-12-31 | $1.37 |
| 2014-09-30 | $1.59 |
| 2014-06-30 | $1.64 |
| 2014-03-31 | $1.31 |
| 2013-12-31 | $1.44 |
| 2013-09-30 | $1.63 |
| 2013-06-30 | $1.62 |
| 2013-03-31 | $1.56 |
| 2012-12-31 | $1.27 |
| 2012-09-30 | $1.53 |
| 2012-06-30 | $1.56 |
| 2012-03-31 | $1.63 |
| 2011-12-31 | $1.37 |
| 2011-09-30 | $1.31 |
| 2011-06-30 | $1.20 |
| 2011-03-31 | $1.23 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $22.407B | $13.009B |
| Labcorp Holdings Inc. provides laboratory services which helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Labcorp Holdings Inc., formerly known as LABORATORY CP, is based in BURLINGTON, N.C. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $157.813B | 28.64 |
| HCA Healthcare (HCA) | United States | $113.378B | 17.58 |
| CVS Health (CVS) | United States | $95.741B | 11.01 |
| Elevance Health (ELV) | United States | $75.968B | 11.33 |
| Cencora (COR) | United States | $70.528B | 22.74 |
| Natera (NTRA) | United States | $31.966B | 0.00 |
| DiDi Global (DIDIY) | China | $22.168B | 20.48 |
| Medpace Holdings (MEDP) | United States | $16.568B | 41.13 |
| Viatris (VTRS) | United States | $15.756B | 5.87 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.545B | 0.00 |
| ICON (ICLR) | Ireland | $14.422B | 14.31 |
| Solventum (SOLV) | United States | $13.340B | 12.95 |
| BioMerieux (BMXMF) | France | $13.150B | 0.00 |
| CochLear (CHEOY) | Australia | $12.190B | 0.00 |
| Revvity (RVTY) | United States | $12.141B | 21.12 |
| Charles River Laboratories (CRL) | United States | $10.494B | 20.21 |
| Sonic Healthcare (SKHHY) | Australia | $8.046B | 0.00 |
| Avantor (AVTR) | United States | $7.548B | 11.53 |
| HealthEquity (HQY) | United States | $7.439B | 27.82 |
| BrightSpring Health Services (BTSG) | United States | $7.302B | 43.54 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.580B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $5.940B | 39.00 |
| PACS (PACS) | United States | $5.544B | 33.71 |
| Sotera Health (SHC) | United States | $5.199B | 25.07 |
| Alignment Healthcare (ALHC) | United States | $4.532B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $2.862B | 50.26 |
| Concentras Parent (CON) | United States | $2.839B | 17.72 |
| Organon (OGN) | United States | $2.132B | 2.25 |
| Progyny (PGNY) | United States | $2.087B | 41.03 |
| Establishment Labs Holdings (ESTA) | United States | $2.070B | 0.00 |
| Surgery Partners (SGRY) | United States | $1.914B | 24.67 |
| Pediatrix Medical (MD) | United States | $1.841B | 10.99 |
| Ardent Health (ARDT) | United States | $1.230B | 4.01 |
| Nutex Health (NUTX) | United States | $1.140B | 8.72 |
| CareDx (CDNA) | United States | $1.050B | 17.16 |
| Teladoc Health (TDOC) | United States | $0.953B | 0.00 |
| Omada Health (OMDA) | United States | $0.861B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.774B | 12.67 |
| InnovAge Holding (INNV) | United States | $0.773B | 0.00 |
| Embecta (EMBC) | United States | $0.648B | 3.68 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.635B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.616B | 0.00 |
| Enhabit (EHAB) | United States | $0.545B | 24.48 |
| SBC Medicals (SBC) | United States | $0.505B | 9.28 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.482B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.408B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.391B | 82.38 |
| Auna S.A (AUNA) | Luxembourg | $0.356B | 5.73 |
| Agilon Health (AGL) | United States | $0.343B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.294B | 0.00 |
| So-Young (SY) | China | $0.284B | 0.00 |
| Oncology Institute (TOI) | United States | $0.264B | 0.00 |
| Beauty Health (SKIN) | United States | $0.191B | 0.00 |
| LifeMD (LFMD) | United States | $0.158B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.131B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.107B | 0.00 |
| Biodesix (BDSX) | United States | $0.082B | 0.00 |
| DocGo (DCGO) | United States | $0.076B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.071B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.042B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.042B | 0.00 |
| Pomdoctor - (POM) | China | $0.025B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.03 |
| OSR Holdings (OSRH) | United States | $0.014B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.014B | 0.00 |
| Lifeward (LFWD) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |